Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News aTyr Pharma Inc ATYR

Healthcare Biotechnology

aTyr Pharma, Inc. is a clinical-stage biotechnology company. The Company is leveraging intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. Its lead therapeutic candidate is efzofitimod, a biologic immunomodulator in clinical development for the treatment of interstitial lung disease (ILD), a group of immune-mediated disorders that can cause... see more

Add To Watchlist

Recent & Breaking News (NDAQ:ATYR)

Life Technologies Launches Industry's First Stem Cell Characterization Panel

PR Newswire June 12, 2013

Life Technologies Launches Compendia Oncomine® NGS Power Tools for Cancer Researchers, Discovers Novel Gene Fusions

PR Newswire June 10, 2013

Life Technologies Begins Shipping QuantStudio(TM) 3D Digital PCR System

PR Newswire June 10, 2013

Biotech Services Take Advantage of Technological Revolution through Innovations - Research Report on Life Technologies, PerkinElmer, PAREXEL, Genomic Health, and Bio-Reference

PR Newswire June 7, 2013

CollabRx Reports Fourth Quarter and Fiscal Year 2013 Financial Results

Globe Newswire June 3, 2013

Today's Research on LIFE, OPK, BKD, MDCO, and DVA

Accesswire May 16, 2013

American CryoStem Partners with Rutgers for Novel Wound Care Product

Accesswire May 14, 2013

New Ion PGM(TM) Solution Outperforms Competitor on Major Performance Metrics for Benchtop Sequencing

PR Newswire May 14, 2013

Patent Protection for TAL Effector Technology Enables Licensing Path for Life Technologies Customers

PR Newswire May 13, 2013

Key to Success, How to Profit: LIFE, BIIB, ETN and AXP

Marketwired May 3, 2013

Life Technologies Supports Global Effort to Help Accelerate Emergency Screening of Avian Influenza (H7N9) Virus

PR Newswire April 26, 2013

Lifshitz Law Firm Announces Investigation of Anaren, Inc., Archon Corporation, Life Technologies Corporation and National Financial Partners Corp.

PR Newswire April 22, 2013

Life Technologies Corp. (LIFE) Investor Lawsuit Against Takeover by Thermo Fisher Scientific Inc. Announced by Shareholders Foundation

Globe Newswire April 22, 2013

Law Office of Brodsky & Smith, LLC Announces Investigation of Life Technologies Corporation

Business Wire April 19, 2013

Life Technologies Partners with Ridom and Releases SeqSphere+ Software to Speed and Simplify Bacterial Typing

PR Newswire April 18, 2013

Mid-day Update On Most Active Stocks: (NASDAQ: LIFE), (NASDAQ: ONNN)

Accesswire April 17, 2013

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Life Technologies Corporation in Connection with the Sale of the Company to Thermo Fisher Scientific, Inc.

PR Newswire April 17, 2013

Investor Alert: Former Attorney General of Louisiana and Kahn Swick & Foti, LLC Investigate Life Technologies Corporation Following Announcement of Proposed Sale of Company to Thermo Fisher Scientific

Business Wire April 16, 2013

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Life Technologies Corporation in Connection with the Sale of the Company to Thermo Fisher Scientific, Inc.

Business Wire April 16, 2013

Ryan & Maniskas, LLP Announces Investigation of Life Technologies Corporation

PR Newswire April 16, 2013